glp-1 drugs pharmaceutical companies partnerships 2025 Market Size to Hit USD 212.73 Billion by 2035 Looming GLP-1 drug patent expirations
Description
Highlights of Prescribing Information: Wegovy (semaglutide) tablets, for oral use
government data shows, and around 12% say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF
The GLP-1 supplement category barely existed before 2023
We only needed approval from the institutional review board' (Nair)
